Recent reports suggest HRT with estrogen is associated with reduced risk for colon cancer and studies at Emory and elsewhere are evaluating links between estrogen replacement and delaying Alzheimer's disease. There still exists some controversy over the use of HRT in women with previous history of breast or endometrial cancer. There have been some reports of very small increases in the risk of blood clots in new users. Synthetic progestin derivatives have become standard compliments to estrogen in HRT for their role in reducing risk of uterine endometrial cancer. Natural progesterone drugs may, in fact, be used alone solely to treat uterine cancer.
Research is ongoing.
That is exactly what research teams across the country to trying to determine. Preliminary research suggests growth hormone does appear to be among the most promising of compounds for reducing frailty in older adults, but it is not without side effects. Exacerbation of diabetes, fluid retention and carpal tunnel syndrome in the wrist are associated with its use in human study subjects. In fact, the body makes more DHEA than any other hormone by far. DHEA has recently been touted to prevent cancer and heart disease, improve memory and reduce fat.